agilon health (NYSE:AGL) Cut to Underperform at Bank of America

agilon health (NYSE:AGL) was downgraded by equities research analysts at Bank of America from a “buy” rating to an “underperform” rating in a report issued on Wednesday, FinViz reports. They currently have a $3.00 price target on the stock. Bank of America‘s target price would suggest a potential downside of 14.53% from the stock’s current price.

Other equities research analysts also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft decreased their target price on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Royal Bank of Canada reissued an “outperform” rating and issued a $8.00 price target on shares of agilon health in a report on Wednesday, August 7th. Benchmark reissued a “buy” rating and issued a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Finally, Evercore ISI increased their price target on agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a report on Tuesday, July 9th. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $8.22.

agilon health Trading Down 4.4 %

agilon health stock traded down $0.16 during trading on Wednesday, hitting $3.51. The company’s stock had a trading volume of 11,253,360 shares, compared to its average volume of 5,012,482. The stock has a market capitalization of $1.44 billion, a price-to-earnings ratio of -5.01 and a beta of 0.54. The stock’s fifty day moving average is $4.71 and its 200 day moving average is $5.43. agilon health has a 1-year low of $3.05 and a 1-year high of $20.37. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The firm’s revenue was up 38.7% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.04) earnings per share. As a group, equities research analysts predict that agilon health will post -0.32 EPS for the current year.

Insider Activity at agilon health

In other agilon health news, CEO Steven Sell bought 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were purchased at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.20% of the stock is owned by insiders.

Institutional Investors Weigh In On agilon health

Several large investors have recently modified their holdings of AGL. Neo Ivy Capital Management acquired a new stake in shares of agilon health in the fourth quarter worth $47,000. J.Safra Asset Management Corp boosted its position in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after buying an additional 3,625 shares during the period. CWM LLC boosted its position in shares of agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares during the period. Nisa Investment Advisors LLC acquired a new stake in shares of agilon health in the second quarter worth $60,000. Finally, Bleakley Financial Group LLC acquired a new stake in shares of agilon health in the first quarter worth $65,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.